<DOC>
	<DOC>NCT02881840</DOC>
	<brief_summary>Open-label, non-randomised, single dose study in 6 healthy male subjects to assess the mass balance recovery, metabolite profile, metabolite identification and pharmacokinetics of 14C-labelled APD421</brief_summary>
	<brief_title>Mass-balance Study of [14C]-APD421 in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea and Vomiting</mesh_term>
	<criteria>Healthy males Age 18 to 65 years of age at time of signing informed consent Body mass index (BMI) of 18 to 30 kg/m2 or, if outside the range, considered not clinically significant by the investigator Must be willing and able to communicate and participate in the whole study Must provide written informed consent Must agree to use an adequate method of contraception (as defined in Section 8.4) Must have regular bowel movements (ie average stool production of ≥1 and ≤3 stools per day) Prior participation in another study with a radiation burden of &gt; 0.1 mSv and ≤ 1 mSv in the period of 1 year prior to screening; a radiation burden of &gt; 1 mSv and ≤ 2 mSv in the period of 2 years prior to screening; a radiation burden of &gt; 2 mSv and ≤ 3 mSv in the period of 3 years prior to screening, etc (add 1 year per 1 mSv)</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>